Press release
Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031
Mumps Vaccine Market
๐๐ข๐ฌ๐ญ ๐จ๐ ๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ :
Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Actiza Pharmaceuticals, GlaxoSmithKline plc
๐ ๐จ๐ซ ๐๐ฎ๐ซ๐๐ก๐๐ฌ๐ ๐๐ง๐ช๐ฎ๐ข๐ซ๐ฒ https://www.alliedmarketresearch.com/purchase-enquiry/15770
Though presence of several factors drives the growth of mumps vaccine market, few factors also act as a restraint to the market. Factors such as excessive cost and complex procedures associated with the manufacturing and development of vaccines provide a hindrance to the growth of the market. In addition, stringent rules and regulations associated with the development and distribution of mumps vaccines act as a restraint to the market.
The mumps vaccine market size is segmented on the basis of age group, distribution channel, and region. By age group, the market is bifurcated into pediatric and adult. The pediatric segment was the highest contributor to the market in the year 2021 and is expected to grow at the fastest CAGR of 6.1% during the forecast period. The growth of the segment is attributed to rise in awareness about the mumps vaccination in pediatric population in the developed and developing regions.
By distribution channel, the market is categorized into hospitals & clinics and vaccination centers. In 2021, the hospitals and clinics segment held the largest mumps vaccine market share of the global mumps vaccine market and is expected to grow at the highest CAGR during the forecast period, which is mainly driven by the considerable number of patient visits to the hospitals for mumps vaccination after the pandemic.
North America acquires the major mumps vaccine market share in terms of revenue of the mumps vaccine market in 2021, owing to the prevalence of large number of mumps cases in U.S. and other major regions of North America. On the other hand, Asia-Pacific is expected to register fastest growth with the highest CAGR of 8.6% during the forecast period.
๐๐จ๐ฐ๐ง๐ฅ๐จ๐๐ ๐๐๐ฆ๐ฉ๐ฅ๐ ๐๐๐ฉ๐จ๐ซ๐ญ https://www.alliedmarketresearch.com/request-sample/15770
๐๐๐๐๐ ๐๐๐๐๐๐๐๐๐๐๐๐ ๐๐๐๐๐๐๐ ๐๐ ๐๐๐ ๐๐๐๐๐๐:
Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
Comprehensive quantitative and qualitative insights at segment and sub-segment level
Covid 19 impact trends and perspective
Granular insights at global/regional/country level
Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
Blanket coverage on competitive landscape
Winning imperatives
Exhaustive coverage on 'Strategic Developments' registered by leading players of the market
Contact:
David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Mumps Vaccine Market Expected to Reach $3.5 Billion by 2031 here
News-ID: 3203595 • Views: โฆ
More Releases from Allied Market Research
Bike Trainers Market Navigating Business with CAGR of 6.9% with Revenue of $362. โฆ
According to a new report published by Allied Market Research, titled, "Bike Trainers Market," The bike trainers market size was valued at $162.00 million in 2021, and is estimated to reach $362.6 million by 2031, growing at a CAGR of 6.9% from 2022 to 2031. The smart bike trainers segment is growing at the fastest rate during the forecast period.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/7391
Aโฆ
Online Coaching Market to Observe Highest Growth of USD 11.7 billion with Growin โฆ
According to a new report published by Allied Market Research, titled, "Online Coaching Market," The online coaching market was valued at $3.2 billion in 2022, and is estimated to reach $11.7 billion by 2032, growing at a CAGR of 14% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/A06528
Online coaching is a type of coaching that utilizes the Internet or other electronic means ofโฆ
Travel Accommodation Market is likely to expand US$ 3144.7 billion, at 12.1% CAG โฆ
The travel accommodation market was valued at $797.70 billion in 2023, and is estimated to reach $3144.7 billion by 2035, growing at a CAGR of 12.1% from 2024 to 2035.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/6044
Travel accommodation refers to the various types of lodging options available for people who are traveling away from their homes. It encompasses a wide range of accommodations, including hotels, motels, resorts,โฆ
Hosiery Market Set to Reach USD 62.4 billion by 2032, With a Sustainable CAGR Of โฆ
According to a new report published by Allied Market Research, titled, "Hosiery Market," The hosiery market was valued at $40.5 billion in 2022, and is estimated to reach $62.4 billion by 2032, growing at a CAGR of 4.5% from 2023 to 2032.
Request The Sample PDF Of This Report: https://www.alliedmarketresearch.com/request-sample/2000
Hosiery is a type of clothing that can be worn straight on the bottoms of the feet and legs.โฆ
More Releases for Mumps
Global Measles Mumps And Rubella Mmr Vaccines Market Size by Application, Type, โฆ
USA, New Jersey- According to Market Research Intellect, the global Measles Mumps And Rubella Mmr Vaccines market in the Internet, Communication and Technology category is projected to witness significant growth from 2025 to 2032. Market dynamics, technological advancements, and evolving consumer demand are expected to drive expansion during this period.
The market for measles, mumps, and rubella (MMR) vaccines is steadily expanding as a result of growing vaccination campaigns and greaterโฆ
Mumps Vaccine Market Boosting Technologies, Industry Growth, Demand Status, Tren โฆ
Measles, Mumps, and Rubella (MMR) vaccinations are a mixture of live viruses that are injected. The live viruses are inactivate and cannot reproduce in human cells while the immune system responds and defends against the infection. The MMR vaccine has a long-term effect. The MMR vaccine causes fever, rash, cough, body pain, headache, nausea and severe consequences such as ovaries and testicles infection, deafness, and in rare cases it leadsโฆ
Measles, Mumps and Rubella (MMR) Vaccines Market Opportunity Analysis, 2026 โ โฆ
Measles, mumps, and rubella are the three common contagious airborne diseases that are highly caused by virus transmitted by sneezing and coughing of the infected person, which could lead to serious complications or death among children. Vaccines of these diseases are sold as attenuated viral vaccines, manufactured in a lyophilised formulation, which requires reconstitution with water for injection diluent and are available in two forms i.e. monovalent as well asโฆ
Mumps Market Estimated to Flourish by 2016 โ 2024 : Persistence Market Researc โฆ
Mumps is a contagious disease typically affecting children and caused by the mumps virus. The characteristic of this disease is the initial onset of headache, loss of appetite, muscle aches, tiredness and fever followed by the typical swelling of one or more salivary glands. The disease is transmitted from one person to the other through saliva and/or droplets. Although the symptoms vanish within few days of infection and are usuallyโฆ
Mumps - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Mumps - Pipeline Review, H1 2017 to its growing collection of premium market research reports.
Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Mumps - Pipeline Review, H1 2017, provides an overview of the Mumps (Infectious Disease) pipeline landscape.
Mumps is a contagious disease that leads to painful swelling of the salivary glands. The mumps are caused by a virus.โฆ
Growth Predicted for Mumps Market : 2016 - 2024
Presently, however, the availability of the vaccine has led to a decrease in the number of cases to fewer than 1,000 a year, and epidemics have also become fairly rare. According to the WHO, in the countries where large-scale immunization against mumps has been applied, the incidence of the disease has dropped radically. However, outbreaks do continue to occur and some immunized individuals, who have been in very close contactโฆ
